LIB

2023 - 12 - 6

Post cover
Image courtesy of "Business Wire"

LIB Therapeutics Announces Appointment of Ingrid Choong, PhD as ... (Business Wire)

LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company developing Lerodalcibep, a novel, third-generation PCSK9 inhibitor.

Post cover
Image courtesy of "PharmiWeb.com"

LIB Therapeutics Announces Appointment of Ingrid Choong, PhD as ... (PharmiWeb.com)

Industry veteran brings more than 20 years of broad operational experience in emerging-stage, private and publicly traded biotechnology companies with an ...

Explore the last week